Q2 STOCKS TO BUY

Valeant Pharmaceuticals Intl Inc (VRX) and the $1.2 Million Options Bet

Another dismal day has traders flooding the Valeant Pharmaceuticals Intl Inc (VRX) options pits

Sep 29, 2016 at 3:11 PM
facebook X logo linkedin


Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has plunged 5% to $25.10, as biotech stocks weigh on the broader market. Amid the beatdown, options traders have set their sights on the Canada-based drugmaker -- especially on the put side of the aisle, where contracts are running at 1.7 times the intraday norm.

That said, the most active VRX option is actually the January 2017 30-strike call. International Securities Exchange (ISE) data confirms a sweep 4,400 contracts was bought to open here for $2.70 apiece, resulting in a total net debit of roughly $1.2 million (premium paid * number of contracts * 100 shares per contract). The option bull's goal is for the stock to topple breakeven of $32.70 (strike plus premium paid) by January expiration. Of course, given that 26.4 million VRX shares are sold short, as well as the deep out-of-the-money nature of the strike, it's possible the call buyer could be a short seller hedging her bearish stock position against an unforeseen breakout.

Taking a step back, calls have been the options of choice lately at the ISE, Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX). VRX's 20-day call/put volume ratio is a top-heavy 2.48, with long calls more than doubling puts. What's more, the stock's Schaeffer's put/call open interest ratio (SOIR) of 0.77 ranks in the call-skewed 9th percentile of its annual range.

Technically speaking, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has been nothing short of a disaster -- pressured by a string of drug pricing scandals. Year-over-year, the biotech stock has tanked 86%, and it currently shows signs of tumbling further under the weight of its descending 30-week moving average.

Schaeffer's Expiration Week Countdown subscribers just made 24% GAINS on Valeant Pharmaceuticals (VRX) puts! Sign up now for a trial subscription.

 
 

“Buy This Stock Now!” - Expert Who Called 11x On TSLA

He called a rare 11x on Tesla…

But now, thanks to Elon & Trump’s new alliance…

He says there’s a new opportunity that could be 1,000x BIGGER than Tesla – and it could completely revolutionize a $23 Trillion market.

It’s trading for less than $5 per share right now…

But it won’t be under the radar for long.

Discover The 1,000x Bigger Elon Opportunity Here

GRAND SLAM COUNTDOWN

 
 

Featured Articles from Trusted Partners:

👀Learn How Dividends Create Passive Income for Life
Receive $200 Off Motley Fool Epic. The Motley Fool Epic $299 discounted offer is based on $499/year list price. Introductory promotion for new members only. Take control of your money and your portfolio with Motley Fool Epic.

💵New Income System Could Pay You $4,243 Monthly
You could collect an average of $4,243 per month starting as early as next week with a new payout system for income investors. New registrations are being accepted for investors who want to be in a position to start with their first payout next week.

🚀Easy 92% Crypto Dividends (No Coins Required)
COIN stock doesn't pay a dividend... But there's actually a new way to collect a massive dividend that's indirectly based on the stock and offers a terrific monthly income (currently yielding nearly 92% on a forward basis).

🤝Free Advisor Match with Wiseradvisor.com
Don't leave your retirement to chance! Get matched with a trusted financial expert for FREE and make the most of your tax refund. Get started now.

⚠️Dennis Quaid's #1 Warning for Americans
Here's the thing: life doesn't come with guarantees. The economy shifts, markets stumble, and years of hard work could slip through your fingers like sand. But it doesn't have to be that way for you. So request a free copy of this Gold & Silver Guide that will arrive right to your doorstep when you act now.

 

 
 

Follow us on X, Follow us on Twitter